Cullinan Oncology Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cullinan Oncology Inc
TickerCGEM
CIK #0001789972
CUSIP230031106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
AddressOne Main Street Suite 520, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2026
[0001789972] 10-K
[0001789972] 10-Q
[0001789972] 3
[0001789972] 4
[0001789972] 5
[0001789972] 8-K
[0001789972] SC 13D
[0001789972] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Kynam Capital Management LP Cullinan Therapeutics Inc [2026-03-04] 0.0
Vanguard Group Inc Cullinan Therapeutics Inc [2026-01-30] 0.0
Lynx1 Capital Management LP Cullinan Therapeutics Inc [2025-08-14] 0.0
Citadel Advisors LLC Cullinan Therapeutics Inc [2025-08-06] 0.0
BlackRock Inc Cullinan Therapeutics Inc [2024-11-08] 7.5
BlackRock Inc Cullinan Therapeutics Inc [2024-10-22] 7.5
Flynn James E Cullinan Therapeutics Inc [2024-04-24] 5.71
Blue Owl Capital Holdings LP Cullinan Oncology Inc [2024-02-14] 7.99
Franklin Resources Inc Cullinan Oncology Inc [2024-02-06] 7.7
BlackRock Inc Cullinan Oncology Inc [2024-01-29] 5.8
BlackRock Inc Cullinan Oncology Inc [2023-02-03] 5.5
CHI Advisors LLC Cullinan Oncology Inc [2022-02-11] 5.67
Jovan-Embiricos Morana Cullinan Oncology Inc [2022-02-10] 4.8
Vanguard Group Inc Cullinan Oncology Inc [2022-02-09] 5.42
Biotechnology Value Fund L P Cullinan Oncology Inc [2021-11-08] 3.2
UBS Oncology Impact Fund LP Cullinan Management Inc [2021-01-19] 18.3
Foresite Capital Fund V LP Cullinan Management Inc [2021-01-15] 6.6
Form 3/4/5 Filer 2011 - 2026
Cullinan Therapeutics Inc
Michaelson Jennifer
Sumer Jacquelyn L
Fenton Mary Kay
Webster Stephen W
Allen Andrew R
Thistle Mary
Doyle Mittie
Rosenberg Anthony
Meek David D
Jones Jeffrey Alan
Ahmed Nadim
Savill Corrine
Nichols Weston
Lynx1 Capital Management LP
Martin Anne-Marie
Ryan David P
Ebeling Thomas
Nguyen Nate
Trigilio Jeffrey
Baeuerle Patrick
Gadicke Ansbert
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Jovan-Embiricos Morana
F2 Vision SCS
F2 Bioscience I 2017 Ltd
Zawel Leigh
Keane Raymond T
Oncology Impact Fund Cayman Management LP
MPM BioImpact LLC
UBS Oncology Impact Fund LP
MPM Oncology Impact Management GP LLC
F2 - TPO Investments LLC
F2 GC LLC
Globeways Holdings Ltd
F2 MC LLC
F2 MG Ltd
F2 Bio TD LLC
Hughes Owen
Wigginton Jon Marc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Michaelson Jennifer
Common Stock
2026-03-05 Sell 8,000 $15.68 125,440
Michaelson Jennifer
Stock Option (Right to Buy) · derivative
2026-03-05 Option exercise 4,000 $0.00
Michaelson Jennifer
Common Stock
2026-03-05 Option exercise 4,000 $4.30 17,200
Michaelson Jennifer
Common Stock
2026-02-25 Sell 1,780 $14.14 25,169
Ahmed Nadim
Common Stock
2026-02-24 Sell 13,515 $14.47 195,562
Sumer Jacquelyn L
Common Stock
2026-02-24 Sell 3,601 $14.47 52,106
Jones Jeffrey Alan
Common Stock
2026-02-24 Sell 4,582 $14.47 66,302
Michaelson Jennifer
Common Stock
2026-02-24 Sell 3,601 $14.47 52,106
Michaelson Jennifer
Common Stock
2026-02-23 Sell 1,752 $13.99 24,510
Sumer Jacquelyn L
Common Stock
2026-02-20 Sell 3,742 $13.62 50,966
Ahmed Nadim
Common Stock
2026-02-20 Sell 16,381 $13.62 223,109
Michaelson Jennifer
Stock Option (Right to Buy) · derivative
2026-02-20 Option exercise 8,000 $0.00
Michaelson Jennifer
Common Stock
2026-02-20 Option exercise 8,000 $4.30 34,400
Michaelson Jennifer
Common Stock
2026-02-20 Sell 3,742 $13.62 50,966
Michaelson Jennifer
Common Stock
2026-02-20 Sell 8,000 $14.30 114,400
Fenton Mary Kay
Common Stock
2026-02-20 Sell 4,398 $13.62 59,901
Jones Jeffrey Alan
Common Stock
2026-02-20 Sell 4,982 $13.62 67,855
Fenton Mary Kay
Stock Option (Right to Buy) · derivative
2026-02-18 Grant 137,500 $0.00
Ahmed Nadim
Stock Option (Right to Buy) · derivative
2026-02-18 Grant 828,000 $0.00
Jones Jeffrey Alan
Stock Option (Right to Buy) · derivative
2026-02-18 Grant 300,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 174 63,700,360
2025-12-31 154 63,294,413
2025-09-30 145 60,858,362
2025-06-30 144 63,315,177
2025-03-31 150 64,475,435
2024-12-31 148 65,722,806
2024-09-30 138 65,718,460
2024-06-30 136 62,999,837
2024-03-31 114 41,648,289
2023-12-31 114 37,833,248
2023-09-30 107 38,269,713
2023-06-30 107 36,881,027
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 80,648 80,648
TEMA ETFS LLC [2026-06-30] SOLE 62,826 62,826
Assenagon Asset Management SA [2026-06-30] SOLE 61,682 61,682
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 575 11,168
Curated Wealth Partners LLC [2026-06-30] OTR 0 10,000
Gamma Investing LLC [2026-06-30] DFND 1,928 1,928
Farther Finance Advisors LLC [2026-06-30] SOLE 0 849
Bangor Savings Bank [2026-06-30] SOLE 842 842
IFP Advisors LLC [2026-06-30] SOLE 728 728
Fortitude Family Office LLC [2026-06-30] SOLE 192 192
True Wealth Design LLC [2026-06-30] SOLE 0 71
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 27 27
Capital Advisors Ltd LLC [2026-06-30] SOLE 0 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com